MiMedx Group, Inc. Detailed Financials

Full historical quarterly statements

Metric	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	64.4M	59.0M	118.1M	113.7M	98.6M	88.2M	92.9M	84.1M
Cost of Goods Sold	20.0M	17.4M	19.1M	18.7M	18.7M	16.6M	16.9M	15.3M
Gross Profit	44.4M	41.6M	99.0M	95.0M	79.9M	71.6M	76.0M	68.7M
R&D Expenses	2.8M	4.1M	4.8M	3.7M	3.3M	3.3M	3.6M	2.9M
Operating Expenses	62.6M	57.7M	77.8M	72.8M	67.6M	63.4M	64.9M	57.6M
Operating Income	-18.5M	-16.0M	21.1M	22.2M	12.4M	8.3M	11.1M	11.2M
Other Income / Gains	686K	718K	718K	659K	637K	361K	195K	257K
Net Income	-14.8M	-10.9M	15.2M	16.7M	9.6M	7.0M	7.4M	8.1M
EPS (Diluted)	-0.10	-0.07	0.10	0.11	0.065	0.05	0.051	0.055
Reported Currency	USD	USD	USD	USD	USD	USD	USD	USD
Gross Profit Ratio	0.69	0.706	0.839	0.835	0.811	0.812	0.818	0.818
General And Administrative Expenses	0	9.3M	0	15.3M	16.3M	0	0	0
Selling And Marketing Expenses	0	43.9M	0	53.7M	47.9M	0	0	0
Selling General And Administrative Expenses	59.8M	53.2M	73.1M	69.0M	64.2M	60.0M	61.1M	54.2M
Other Expenses	0	301K	0	112K	100K	99K	287K	490K
Cost And Expenses	82.5M	75.0M	97.0M	91.5M	86.2M	80.0M	81.9M	72.9M
Interest Income	0	1.3M	1.3M	0	1.2M	984K	2.9M	278K
Interest Expense	0	402K	405K	785K	475K	478K	2.5M	0
Depreciation And Amortization	0	1.6M	3.2M	5.3M	3.1M	3.2M	3.0M	1.2M
Ebitda	-18.5M	-13.7M	25.4M	28.9M	16.6M	12.3M	14.1M	12.6M
Ebitdaratio	-0.287	-0.232	0.215	0.254	0.169	0.14	0.152	0.15
Operating Income Ratio	-0.287	-0.272	0.178	0.195	0.125	0.094	0.119	0.133
Income Before Tax	-17.8M	-15.3M	21.8M	22.8M	13.0M	8.6M	11.2M	11.4M
Income Before Tax Ratio	-0.276	-0.26	0.185	0.201	0.132	0.098	0.121	0.136
Income Tax Expense	2.9M	-4.5M	6.6M	6.1M	3.4M	1.6M	3.8M	3.5M
Net Income Ratio	-0.231	-0.184	0.129	0.147	0.098	0.08	0.08	0.096
Epsdiluted	-0.10	-0.07	0.10	0.11	0.064	0.05	0.05	0.055
Weighted Average Shs Out	147.8M	148.4M	147.8M	148.0M	147.8M	147.3M	147.0M	147.0M
Weighted Average Shs Out Dil	147.8M	148.4M	149.7M	149.7M	149.3M	149.7M	149.0M	148.4M